Imeka
PrivateLast Round
Grant
Oct 24, 2023
Total Funding Raised
$1.79M
Company Overview
Imeka is a healthtech company that provides AI-powered medical imaging software to analyze brain white matter connectivity for clinical and pharmaceutical research applications.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Clinical Trials, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Imeka Comparables
Compare Imeka with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Qynapse | 82% | |
| Biospective Inc. | 79% | |
| IXICO plc | 78% | |
Imeka Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 24, 2023 | ||||
| Debt | Jul 25, 2023 | ||||
| Seed | Dec 14, 2017 |
Imeka Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hacking Health Accelerator | Seed |
| Creative Destruction Lab | Seed |
| Desjardins Capital | Seed |
| Canada Economic Development for Quebec Regions | Debt, Seed |
| Sherbrooke Innopole | Seed |
| Alzheimer's Drug Discovery Foundation | Grant |
Imeka Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Imeka's valuation, stock price, and market status.